{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:03:50Z","timestamp":1790795030826,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nano.2015.02.020","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T14:25:53Z","timestamp":1426775153000},"page":"1133-1140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy"],"prefix":"10.1016","volume":"11","author":[{"given":"Mark E.","family":"Lobatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Otten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9863-3126","authenticated-orcid":false,"given":"Antoine","family":"Millon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarayu","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten P.M.","family":"Paridaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur M.","family":"van der Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.G.","family":"Stroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josbert M.","family":"Metselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6116","key":"10.1016\/j.nano.2015.02.020_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: challenges and opportunities","volume":"339","author":"Tabas","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.nano.2015.02.020_bb0010","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.nano.2015.02.020_bb0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.nano.2015.02.020_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.nano.2015.02.020_bb0025","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nbt1006-1211","article-title":"The emerging nanomedicine landscape","volume":"24","author":"Wagner","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"8 Suppl.","key":"10.1016\/j.nano.2015.02.020_bb0030","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"7347","key":"10.1016\/j.nano.2015.02.020_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"issue":"239","key":"10.1016\/j.nano.2015.02.020_bb0040","doi-asserted-by":"crossref","first-page":"239sr1","DOI":"10.1126\/scitranslmed.3005101","article-title":"Imaging and nanomedicine in inflammatory atherosclerosis","volume":"6","author":"Mulder","year":"2014","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.nano.2015.02.020_bb0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd3578","article-title":"Perspectives and opportunities for nanomedicine in the management of atherosclerosis","volume":"10","author":"Lobatto","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.nano.2015.02.020_bb0050","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1021\/mp100309y","article-title":"Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis","volume":"7","author":"Lobatto","year":"2010","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.nano.2015.02.020_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0731-7085(86)80042-5","article-title":"HPLC determination of glucocorticoid alcohols, their phosphates and hydrocortisone in aqueous solutions and biological fluids","volume":"4","author":"Derendorf","year":"1986","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.nano.2015.02.020_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-391860-4.00011-2","article-title":"Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging","volume":"508","author":"Lobatto","year":"2012","journal-title":"Methods Enzymol"},{"issue":"1","key":"10.1016\/j.nano.2015.02.020_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08982100801893978","article-title":"Utility of targeted glucocorticoids in cancer therapy","volume":"18","author":"Banciu","year":"2008","journal-title":"J Liposome Res"},{"issue":"4","key":"10.1016\/j.nano.2015.02.020_bb0070","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/mp2000742","article-title":"Liposomal drug formulations in the treatment of rheumatoid arthritis","volume":"8","author":"Van den Hoven","year":"2011","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.nano.2015.02.020_bb0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mrm.21532","article-title":"MR imaging of adventitial vasa vasorum in carotid atherosclerosis","volume":"59","author":"Kerwin","year":"2008","journal-title":"Magn Reson Med"},{"issue":"2","key":"10.1016\/j.nano.2015.02.020_bb0080","first-page":"87","article-title":"Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis. Angiogenesis","volume":"13","author":"Calcagno","year":"2010"},{"issue":"9","key":"10.1016\/j.nano.2015.02.020_bb0085","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.nano.2015.02.020_bb0090","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2967\/jnumed.107.050294","article-title":"Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations","volume":"49","author":"Rudd","year":"2008","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.nano.2015.02.020_bb0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1568026611313040004","article-title":"Toxicity of magnetic resonance imaging agents: small molecule and nanoparticle","volume":"13","author":"Chang","year":"2013","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"10.1016\/j.nano.2015.02.020_bb0100","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.11140","article-title":"Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes","volume":"48","author":"Metselaar","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T03:58:53Z","timestamp":1537761533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1549963415000702"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.02.020","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}